UNC-51/ULK1 is a serine/threonine kinase that initiates autophagy by phosphorylating downstream substrates like ATG13 and FIP200 . It regulates processes such as bacterial clearance , axonal transport , and mitochondrial homeostasis . Antibodies targeting UNC-51/ULK1 enable researchers to study its expression, post-translational modifications, and interactions in diverse biological systems.
These antibodies are validated for specificity and sensitivity across species and experimental conditions:
ULK1 (R600) #4773: Detects endogenous ULK1 in human and monkey cells . Used in studies linking ULK1 to xenophagy and DNA damage-induced autophagy .
ULK1 (D9D7) #6439: Monoclonal antibody validated for IP and WB, critical for analyzing ULK1 kinase activity in cancer models .
Abcam ab167139: Recognizes ULK1 in human, mouse, and rat tissues, with applications in neurodevelopmental studies .
ULK1 antibodies confirmed its role in bacterial ubiquitylation and p62 recruitment during Listeria monocytogenes clearance .
Phosphorylation of p62 at S409, mediated by ULK1, enhances ubiquitin affinity and autophagosome formation .
Antibodies revealed ULK1’s interaction with UNC-14 and kinesin motors for axonal transport in Drosophila and C. elegans .
ULK1 deficiency disrupts synaptic vesicle transport, leading to axonal defects .
ULK1 inhibition via RPM-1 ubiquitin ligase activity modulates autophagy in neurodegenerative models .
Antibodies identified ULK1 as a therapeutic target in cancers, with inhibitors like SBI-0206965 blocking autophagic flux .
Western Blotting: Use 1:1000 dilution for ULK1 (D9D7) #6439 in RIPA buffer .
Immunoprecipitation: Optimize lysates with protease/phosphatase inhibitors .
ULK1-p62 Axis: ULK1 phosphorylates p62 at S409 to enhance bacterial targeting .
Cancer Therapy: ULK1 inhibitors (e.g., MRT68921) synergize with chemotherapy by blocking cytoprotective autophagy .
Lipotoxicity: ULK1 degrades KEAP1 to activate NFE2L2, mitigating palmitic acid-induced cell death .
Cross-Reactivity: Some antibodies may detect ULK2 due to homology .
Post-Translational Modifications: Phosphorylation or ubiquitination can alter ULK1’s molecular weight, complicating WB interpretation .
Develop isoform-specific antibodies to distinguish ULK1/ULK2 functions.
Optimize antibodies for spatial proteomics to map ULK1’s subcellular dynamics.
Here’s a structured FAQ for researchers working with unc-51 antibody in academic contexts, synthesized from peer-reviewed studies and technical methodologies:
Use kinase-dead mutants (e.g., unc-51 K38A) to dissect phosphorylation-dependent vs. independent roles .
Combine autophagy reporters (e.g., LC3-II puncta) with UNC-51 knockdown in neuron-specific models .
Axon guidance: UNC-51/UNC-14 complexes mediate growth cone dynamics via SynGAP interaction .
Axon termination: RPM-1 ubiquitinates UNC-51 to inhibit its activity, ensuring proper synapse maturation .
Strategy:
Negative controls:
Positive controls:
Model system: Use Drosophila mushroom body neurons, where UNC-51 regulates both dendritic overshooting and axonal Fas II trafficking .
Tools:
Readouts: